Corient Private Wealth’s JLens 500 Jewish Advocacy U.S. ETF TOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09K Sell
39,936
-39,936
-50% -$1.14M ﹤0.01% 2818
2025
Q4
$2.29M Buy
79,872
+39,936
+100% +$1.14M ﹤0.01% 1459
2025
Q3
$1.12M Hold
39,936
﹤0.01% 1379
2025
Q2
$1.04M Buy
+39,936
New +$960K ﹤0.01% 1347

Other funds holding TOV

Corient Private Wealth's TOV Position: Q1 2026 in Review

Corient Private Wealth reduced its JLens 500 Jewish Advocacy U.S. ETF (TOV) stake by 50% in Q1 2026, selling an estimated $1.14M and leaving 39,936 shares worth $1.09K. The position accounts for ﹤0.01% of the portfolio, ranked #2818.

Corient Private Wealth first reported a position in TOV in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.29M in Q4 2025. 22 funds tracked by Wall St. Rank hold TOV as of Q1 2026.

  • Corient Private Wealth held 39,936 shares of JLens 500 Jewish Advocacy U.S. ETF worth $1.09K as of Q1 2026.
  • Corient Private Wealth sold 39,936 JLens 500 Jewish Advocacy U.S. ETF shares in Q1 2026, an estimated $1.14M.
  • JLens 500 Jewish Advocacy U.S. ETF made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #2818 holding.
  • Corient Private Wealth first reported a position in JLens 500 Jewish Advocacy U.S. ETF in Q2 2025 and has held it in 4 quarters since.
  • Corient Private Wealth's JLens 500 Jewish Advocacy U.S. ETF position peaked at $2.29M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held JLens 500 Jewish Advocacy U.S. ETF as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.